Partner Perspectives | Fingerpaint Group
3 Steps to Supercharge Your Rare Disease Advocacy Partnerships
Dan Schroen, Brand Insights Contributor, Head of Photo 51, a Fingerpaint company;Paul Hagopian, Brand Insights Contributor, Head of Fingerpaint’s Bay Area office
October 11th 2021How these actions can help brand teams form effective and sustainable relationships with patient communities
Solving Access Challenges in Today’s Market
Andy Pyfer, Brand Insights Contributor, Partner, Fingerpaint;Roshawn Blunt, Brand Insights Contributor, Managing Director of 1798, a Fingerpaint company
April 30th 2020New drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.
How Rare Disease Marketing Will Stretch Beyond the Patient
Laura Wilson, Brand Insights Contributor, Patient Strategy, Fingerpaint;Jonathan Romeo, Brand Insights Contributor, Brand Strategy, Fingerpaint
January 31st 2020The foundation of a strong rare disease marketing program must be built on the comprehensive knowledge of how the life-altering disease impacts all areas of a patient’s life.
